Nubank (NYSE:NU) is exceptional value at the current price
retained text
This is more a name drop for those looking for suggestions than a sales pitch I used to see this stock mentioned a lot, but it seems to have fallen out of favour lately. People talk about MELI but this is a far more compelling value proposition Nubank is LatAm's biggest fintech - centered in Brazil where it already has a dominant position in eBanking serving more than 60% of the population - but currently expanding into Mexico and Columbia where it is experiencing extremely strong growth Nubank provide both deposit services as well as lending to the "underserved" market. In terms of deposits they are incredibly popular because they offer fair rates of interest on money which the old world banking sector does not, and cannot, as they have bricks and mortar to maintain. Nubank's model on the other hand is asset light. Most of their customers use it as their primary banking app, which provides Nubank a huge float and network. In terms of lending services they are mostly focussed on very high margin short term unsecured credit card lending. Their NIM is a little over 12.5%, compared to a typical 2% from the legacy sector. This makes Nubank's ROIC/ROE extreme (27% and 31.5% respectively), but obviously poses higher risk than the secured mortgage lending predominant in the legacy sector. Nubank answer this concern by unique use of AI tools to assess and predict customer behaviour in real time, and adjust lending accordingly. Despite the apparent high risk of their loan book, Nubank has a NPL ratio which is remarkably comparable to the NPL ratio of the legacy sector, 90 day NPL around 6.9% vs sector 5.5%. In addition, they hold a very high provison for NPLs, around 250% of NPL book, so any future increase in losses has largely already been accounted for. Not to say they couldn't experience any issues during a recession, but even in an extreme stress scenario, they are unlikely to lose even a single years net income Further, Nubank is transitioning to more secured lending by using the Brazilian payroll scheme, whereby borrowers can opt to have the monthly repayment deducted directly from their paycheck, presenting near zero default risk In terms of growth, Nubank pursues a multi-layered strategy, where they not only aim to grow the number of customers, but also the revenue per customer, and at the same, their asset light model contributes economy of scale and very low incremental costs to revenue. Even in Brazil, where they are already dominant serving 60% of the population, revenue has grown 52% YoY despite customer numbers only growing 12.5%, due to cross-selling of services including insurance, investment, and premium tiers Mexico is in a still early stage of growth. Here Nubank serve only 16% of the population, the customer growth rate is 46% YoY, and revenue growth rate is 79% Columbia is in an even earlier stage - 13% of population served, 65% user growth, and 31% revenue growth (revenue growth is consciously lower here while they break into the market, then the revenue per customer is grown at far higher rates later, as in Brazil and Mexico) This is a rare company that fits the quote in bar at top of sub: > The best kind of business to own is one that over an extended period can employ large amounts of incremental capital at very high rates of return And it's available at 13.8x one year forward earnings, 8.6x three year forward. Allow that to sink in because it is truly remarkable. Yes, it's emerging market, but if you compare this to the likes of MELI or even DLO (which I am also a fan of btw), the multiples are still excellent You are also getting a heavy discount due to the drop of the Brazilian Real last week Still founder ran, with insiders holding 23% of the shares - I'd consider that within the optimal range Okay this turned out to be a bit more than a name drop, lol. Hope it's interesting to someone
document fetched 2026-11-08 00:35 · canonical https://reddit.com/r/ValueInvesting/comments/1xq9elf/nubank_nysenu_is_exceptional_value_at_the_current